Lixisenatide also showed small but significant benefits for urinary albumin to creatinine ratio (24% vs 24% from baseline to month 24), weight loss (-0.7 kg) and blood pressure (-0.8 mm Hg)
Tirzepatide is a dual agonist it targets both GLP-1 and GIP receptors
However, clinical studies consistently demonstrate substantial reductions in waist circumference and visceral adipose tissue volume, suggesting that abdominal fat responds as part of generalized fat loss with these medications
Lv L, Shen Z, Zhang J, Zhang H, Dong J, Yan Y, Liu F, Jiang K, Ye Y, Wang S (2014) Clinicopathological significance of SIRT1 expression in colorectal adenocarcinoma
L-Carnitin sorgt hier als Gepcktrger dafr, dass die Fettsuren erst berhaupt zu den Mitochondrien kommen